Skip to main content
. 2024 Aug 28;8(6):923–934. doi: 10.1007/s41669-024-00520-8

Fig. 3.

Fig. 3

Cost savings and QALYs across patient populations with baseline OCS daily doses of 5, 10 and 15 mg (deterministic, by time horizon). OCS oral corticosteroids, QALY quality-adjusted life-year